Drug-Resistant Epilepsy
On this page
Direct answer
Failure of adequate trials of two tolerated, appropriately chosen and appropriately used antiepileptic drug schedules — whether as monotherapy or in combination — defines drug-resistant epilepsy by the ILAE criterion. Roughly a third of epilepsy patients reach this point, and the correct next step is not an endless parade of third and fourth drugs but referral for presurgical evaluation, because the chance of seizure freedom with each additional medication falls steeply after two failures while surgery — best established for drug-resistant mesial temporal lobe epilepsy — can render around 60 to 80 per cent of well-selected patients seizure-free.
What you must remember
- The definition demands two failures of appropriate drugs at adequate doses for the correct seizure type; pseudoresistance (wrong drug, wrong dose, poor adherence, wrong diagnosis) must be excluded first.
- After two failed appropriate drugs, the probability of seizure freedom with subsequent medications falls to well under 20 per cent cumulatively — continue-and-wait is not a neutral strategy.
- Non-epileptic (psychogenic, dissociative) seizures account for a meaningful share of "refractory" cases; video-EEG monitoring is the gold standard for diagnosing the events themselves.
- The best surgical candidate: mesial temporal lobe epilepsy with hippocampal sclerosis on MRI, concordant scalp EEG and semiology — anterior temporal lobectomy achieves seizure freedom in roughly 60 to 80 per cent, supported by a landmark randomised trial (Wiebe, 2001).
- Other procedures: lesionectomy around an epileptogenic structural lesion, hemispherectomy for catastrophic hemisphere-wide paediatric syndromes, corpus callosotomy chiefly for atonic drop attacks, multiple subpial transection for eloquent cortex.
- Vagus nerve stimulation and deep brain stimulation (anterior thalamic nucleus) are palliative neuromodulation options that reduce seizure frequency rather than aim for cure.
- Ketogenic diet has its strongest evidence in children, including GLUT1 deficiency and Dravet syndrome, and requires dietetic supervision.
- Every patient on enzyme-inducing antiepileptics long term needs calcium and vitamin D attention — bone health is part of chronic refractory care.
From second failure to operation, in order
A 31-year-old has focal impaired-awareness seizures despite carbamazepine and then levetiracetam, each pushed to tolerated doses with levels checked. Step one is auditing the diagnosis: the events are video-EEG-confirmed epileptic, the MRI has been done on an epilepsy protocol — it shows left hippocampal sclerosis — and adherence has been verified, so this is true drug resistance, not pseudoresistance. Step two is referral to a comprehensive epilepsy centre rather than an optimistic third monotherapy, because the evidence says the odds have collapsed. Step three is the presurgical conference, where three streams of data must converge on one region: semiology (the rising epigastric aura, the automotor sequence), scalp EEG (anterior temporal interictal spikes, ictal onset), and imaging (the sclerotic hippocampus, often with contralateral normal memory on neuropsychology, verified where necessary by Wada testing or functional MRI). Concordance means proceed to anterior temporal lobectomy; discordance or bilateral lesions means consider invasive foramen ovale or stereo-EEG electrodes first. Step four is the post-operative plan — antiepileptics continue typically for one to two seizure-free years before slow withdrawal, and visual field testing is documented because a superior quadratic defect is a known complication. If the focus had been non-lesional extratemporal or overlapping eloquent cortex, the conversation shifts to neuromodulation or palliative disconnection rather than curative resection — matching the goal to the anatomy is the whole skill.
Where students slip
The classic error is treating "drug-resistant" as a late label earned after five or six drugs; the ILAE definition stops at two failures, and delay costs developmental years in children and driving, employment and bone health in adults. The second confusion is between curative resection and palliative procedures — corpus callosotomy does not remove an epileptogenic focus, it disconnects the spread, and its headline indication is the atonic drop attack; VNS similarly reduces rather than abolishes seizures in most. Finally, candidates forget that non-epileptic seizures lurk inside the refractory population, and video-EEG — not a better drug — is the investigation that uncovers them.
Frequently asked questions
What is the ILAE definition of drug-resistant epilepsy?
Failure of adequate trials of two tolerated, appropriately chosen and appropriately used antiepileptic drug schedules — monotherapy or combinations — to achieve sustained seizure freedom.
Which surgical outcome is the benchmark in temporal lobe epilepsy?
Seizure freedom in roughly 60 to 80 per cent of patients after anterior temporal lobectomy for mesial temporal sclerosis, validated against medical therapy in a randomised trial.
Which procedure is chosen for atonic drop attacks?
Corpus callosotomy, which disrupts bilateral seizure spread; it is palliative and pairs classically with Lennox-Gastaut-type epilepsies.
Why is video-EEG monitoring essential in apparent refractory epilepsy?
It characterises the habitual events and separates epileptic from non-epileptic (dissociative) seizures, while localising ictal onset — the foundation of every surgical decision.
Which dietary therapy has evidence in refractory paediatric epilepsy?
The ketogenic diet, with strongest indications in GLUT1 deficiency and Dravet syndrome, supervised by a dietitian for growth and biochemical monitoring.